These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 1908150

  • 1. Treatment with OKT3 and cyclosporine for acute allograft rejection.
    Schulak JA, Mayes JT, Hricik DE.
    Transplant Proc; 1991 Aug; 23(4):2119-22. PubMed ID: 1908150
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Orthoclone OKT3 treatment of acute renal allograft rejection in patients receiving maintenance cyclosporine therapy.
    Hirsch RL, Layton PC, Barnes LA, Kremer AB, Goldstein G.
    Transplant Proc; 1987 Apr; 19(2 Suppl 1):32-6. PubMed ID: 3105138
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effective induction immunosuppression for cadaver renal transplantation at the St. Francis Regional Medical Center.
    Shield CF.
    Clin Transpl; 1990 Apr; ():265-74. PubMed ID: 2129408
    [Abstract] [Full Text] [Related]

  • 7. OKT3 prophylaxis in cadaveric kidney transplant recipients with delayed graft function.
    Cohen DJ, Benvenisty AI, Cianci J, Hardy MA.
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):19-27. PubMed ID: 2510507
    [Abstract] [Full Text] [Related]

  • 8. Comparison between prophylactic use of OKT3 and cyclosporine in cadaveric renal transplantation.
    De Pauw L, Abramowicz D, Goldman M, Vereerstraeten P, Kinnaert P, Toussaint C.
    Transplant Proc; 1990 Aug; 22(4):1759-60. PubMed ID: 2117800
    [No Abstract] [Full Text] [Related]

  • 9. Use of OKT3 in kidney, pancreas, and liver transplantation.
    D'Alessandro AM, Pirsch JD, Melzer JS, Sollinger HW, Kalayoglu M, Reed A, Knechtle SJ, Belzer FO.
    Transplant Proc; 1990 Aug; 22(4):1748-9. PubMed ID: 2117796
    [No Abstract] [Full Text] [Related]

  • 10. OKT3 treatment of steroid- and/or anti-thymocyte globulin-resistant renal allograft rejection occurring on triple baseline immunosuppression including cyclosporine A.
    Widmer U, Frei D, Keusch G, Burger HR, Largiader F, Binswanger U.
    Transplant Proc; 1988 Oct; 20(5 Suppl 6):90-5. PubMed ID: 3140454
    [No Abstract] [Full Text] [Related]

  • 11. Reversal of steroid- and antithymocyte globulin-resistant acute rejection crises in renal transplantation with monoclonal antibody (OKT3).
    Prieto C, Rodriguez-Paternina E, Andrés A, Morales JM, Farias J, Montoyo C, Regueiro JR, Rodicio JL.
    Transplant Proc; 1990 Aug; 22(4):1753-4. PubMed ID: 2117798
    [No Abstract] [Full Text] [Related]

  • 12. The reuse of OKT3 after previous rejection or induction therapy in cadaveric renal transplantation.
    Shield CF, Hughes JD.
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):35-8. PubMed ID: 2510509
    [Abstract] [Full Text] [Related]

  • 13. Acute renal allograft rejection: the role of monoclonal antibodies in treatment: experience with orthoclonal anti-T3 cell antibody.
    McLigeyo SO, Notghi A, Anderton JL, Dick J.
    East Afr Med J; 1990 Sep; 67(9):667-73. PubMed ID: 2123786
    [Abstract] [Full Text] [Related]

  • 14. Uses of orthoclone OKT3 for prophylaxis of rejection and induction in initial nonfunction in kidney transplantation.
    Kahana L, Ackermann J, Lefor W, Weinstein S, Wright C, DeQuesada A, Alveranga D, Baxter J, Shires D.
    Transplant Proc; 1990 Aug; 22(4):1755-8. PubMed ID: 2117799
    [Abstract] [Full Text] [Related]

  • 15. Renal transplantation with cyclosporine in the elderly population.
    Velez RL, Brinker KR, Vergne-Marini PJ, Nesser DA, Long DL, Trevino G, Dickerman RM, Helfrich GB.
    Transplant Proc; 1991 Apr; 23(2):1749-52. PubMed ID: 1905073
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. First and second course of OKT3 monoclonal anti-T cell antibody for treatment of renal allograft rejection followed by testing for anti-OKT3 IgM and/or IgG immunization.
    Birkeland SA, Bach JF, Chatenoud L, Jørgensen KA, Strate M, Elbirk A, Rohr N, Svendsen V.
    Transplant Proc; 1990 Feb; 22(1):221-2. PubMed ID: 2106740
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.